NYSE · Dividend

Shoulder Innovations, Inc. (SI) Dividend

$20.64 NYSE: SI Market Cap $431.83M

Data as of Nov 16, 2026 (intraday, delayed) · Source: Financial Modeling Prep (methodology)

MetricValue
Dividend YieldNone
Indicated Annual Dividend—
Payout Ratio—
FCF Yield-11.68%
Current Price$20.64

Dividend Analysis

Shoulder Innovations, Inc. (SI) does not currently pay a dividend, based on the latest available data. Companies that do not pay dividends may use earnings for reinvestment, acquisitions, share buybacks, or debt repayment instead.

Free cash flow yield of -11.68% is below the 0.00% dividend yield, so the dividend is not fully covered by free cash flow at the current price.

Dividend yield against peers

Shoulder Innovations, Inc. has the lowest dividend yield of the 9 companies compared here.

CompanyYieldP/EPrice
STERIS plc (Ireland) (STE)1.08%30.38$262.58
Alcon Inc. (ALC)0.49%54.50$73.89
Mesa Laboratories, Inc. (MLAB)0.47%116.10$135.84
QuidelOrtho Corporation (QDEL)0.00%—$10.52
Mobia Medical, Inc. (MOBI)0.00%—$13.17
908 Devices Inc. (MASS)0.00%—$9.24
Anika Therapeutics Inc. (ANIK)0.00%—$13.07
Apyx Medical Corporation (APYX)0.00%—$2.56
Shoulder Innovations, Inc. (SI)0.00%-11.32$20.64

Shoulder Innovations, Inc. (SI) dividend — frequently asked questions

Does Shoulder Innovations, Inc. (SI) pay a dividend?

No, Shoulder Innovations, Inc. (SI) does not currently pay a dividend.

Dividend yields of other Medical - Specialties stocks

ALC yield 0.49%STE yield 1.08%MLAB yield 0.47%All Healthcare stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNYSE High ROE StocksAll stock screens
SI Overview SI Financials Screen Dividend Stocks

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.